Statements (31)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
antiparkinsonian agent anticholinergic agent |
| gptkbp:ATCCode |
N04AC01
|
| gptkbp:CASNumber |
3734-67-6
|
| gptkbp:chemicalFormula |
C21H25NO·CH4O3S
|
| gptkbp:contraindication |
gptkb:myasthenia_gravis
narrow-angle glaucoma |
| gptkbp:discoveredBy |
gptkb:Merck_&_Co.
|
| gptkbp:eliminationHalfLife |
12-24 hours
|
| gptkbp:excretion |
renal
|
| https://www.w3.org/2000/01/rdf-schema#label |
benztropine mesylate
|
| gptkbp:introducedIn |
1954
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
dopamine reuptake inhibitor
muscarinic acetylcholine receptor antagonist |
| gptkbp:metabolism |
hepatic
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
intramuscular intravenous |
| gptkbp:sideEffect |
confusion
constipation blurred vision dry mouth urinary retention |
| gptkbp:synonym |
gptkb:Cogentin
|
| gptkbp:usedFor |
gptkb:Parkinson's_disease
extrapyramidal symptoms |
| gptkbp:bfsParent |
gptkb:benztropine
|
| gptkbp:bfsLayer |
8
|